🦊/People

Sam Blackman

Investor

Entrepreneur in Residence at GV (Google Ventures)

Seattle, Washington, United States

Find your path to Sam

524 people in our graph share verified history with Sam β€” schools, employers, funds. One of them is your warm intro.

Anika GuptaunlockedSam: together at GV (Google Ventures)
Γ—11Sam: together at GV (Google Ventures)

About

Dr. Samuel Blackman is a physician-scientist, pediatric neuro-oncologist, and cancer drug developer who joined GV in 2025 as a life sciences entrepreneur in residence. He co-founded Day One Biopharmaceuticals in 2018 and previously held senior oncology drug development roles at companies including Merck, GlaxoSmithKline, Seattle Genetics, and Juno Therapeutics.

Invests in

BiotechDigital HealthMedical Devices

Experience

  1. GV (Google Ventures)Entrepreneur in Residencecurrent2025 β€” present
  2. Day One BiopharmaceuticalsFounder and Strategic Advisorcurrent2025 β€” presentBrisbane, California, United States
  3. Day One BiopharmaceuticalsFounder and Head of Research and Development2023 β€” 2025South San Francisco, California, United States
  4. Day One BiopharmaceuticalsFounder and Chief Medical Officer2018 β€” 2023South San
  5. Pediatric Brain Tumor FoundationBoard Membercurrent2025 β€” present
  6. Bonum TherapeuticsBoard Membercurrent2024 β€” presentSeattle, Washington, United States
  7. CureSearch for Children's CancerBoard Membercurrent2022 β€” present
  8. Presage Biosciences, Inc.Board Membercurrent2018 β€” presentGreater Seattle Area
  9. Litmus HealthAdvisory Board Membercurrent2016 β€” present
  10. NotableScientific Advisor2019 β€” 2024San Francisco, California, United States
  11. Mavupharma, Inc.Head of Clinical Development2018 β€” 2019Greater Seattle Area
  12. Silverback TherapeuticsSenior Vice President, Head of Clinical Development2016 β€” 2018Seattle, WA
  13. Juno TherapeuticsSenior Medical Director2014 β€” 2016Seattle, WA
  14. Seattle GeneticsExecutive Director, Head of Translational Medicine2012 β€” 2014Bothell, WA
  15. GlaxoSmithKlineDirector, Oncology Early Clinical Development2010 β€” 2012Collegeville, PA
  16. MerckAssociate Director - Experimental Medicine2008 β€” 2010
  17. The Childrens Hospital of PhiladelphiaStaff Physician2008 β€” 2010
  18. Consumers Medical ResourcePhysician Consultant2007 β€” 2009
  19. Dana-Farber Cancer InstituteAttending Physician in Pediatric Oncology2008
  20. Children's Hospital BostonFellow in Pediatric Oncology2004 β€” 2006
  21. American Medical AssociationResident/Fellow Representative - Council on Scientific Affairs2003 β€” 2006
  22. Cincinnati Children's Hospital Medical CenterResident in Pediatrics2001 β€” 2004

Skills & more

OncologyClinical Research33

Languages English Β· Latin

  • American Board of Pediatrics β€” American Board of Pediatrics (ABP)

From Sam's professional profile.

Investments

Board seats

Bonum TherapeuticsPheon TherapeuticsPresage BiosciencesS1 Oncology

Per the firm's website.

Colleagues at GV (Google Ventures)

Frequently asked questions

Who is Sam Blackman?
Dr. Samuel Blackman is a physician-scientist, pediatric neuro-oncologist, and cancer drug developer who joined GV in 2025 as a life sciences entrepreneur in residence. He co-founded Day One Biopharmaceuticals in 2018 and previously held senior oncology drug development roles at companies including Merck, GlaxoSmithKline, Seattle Genetics, and Juno Therapeutics.
Where does Sam Blackman work?
Sam Blackman is Entrepreneur in Residence at GV (Google Ventures).
What does Sam Blackman invest in?
Sam Blackman invests in Biotech, Digital Health, Medical Devices.
What boards does Sam Blackman sit on?
Sam Blackman holds tracked board seats at Bonum Therapeutics, Pheon Therapeutics, Presage Biosciences, S1 Oncology.
Where did Sam Blackman go to school?
Sam Blackman studied at University of Illinois College of Medicine (MD, Medicine); University of Illinois Chicago (PhD, Pharmacology); University of Chicago (BA, Philosophy).

Founder mafias

Same school

Shared employers